Inhibikase Therapeutics Inc logo

Inhibikase Therapeutics Inc

NEW
NAS:IKT (USA)   Ordinary Shares
$ 2.395 +0.050 (+2.14%) 10:08 PM EST
At Loss
P/B:
2.06
Market Cap:
$ 334.19M
Enterprise V:
$ 246.56M
Volume:
309.31K
Avg Vol (2M):
870.57K
Trade In:
Volume:
309.31K
At Loss
Avg Vol (2M):
870.57K

Inhibikase Therapeutics Inc Valuation Measures